EMA published a guidance in forms of Questions and Answers on good clinical practices. (GCP). Table of contents are:
- Investigational medicinal products (IMPs) in bioavailability and bioequivalence trials
- GCP matters
- Expectations of European Union (EU) competent authorities on the use of electronic trial master files
- Records of study subject data relating to clinical trials
February 25, 2021